United Kingdom · 
Who invested in DIOSynVax?
DIOSynVax's investors include Innovate UK and Parkwalk.
2022202320242025
$42MGrant$1.7MRound
United Kingdom · Funded startup
Who invested in DIOSynVax
Funding summaryUpdated 26 Oct 2026
$44Mraised across 2 rounds since 2022, from 2 sources
$42MGrant$1.7MRound
- Latest round
- Round, $1.7MJun 2025
- Biggest round
- $42MGrant · Mar 2022
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $42M Mar 2022
- Biggest round
- $42M Grant · Mar 2022
- Between rounds
- 3.3 years from the last two
The rounds
- Jun 2025Round$1.7M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Mar 2022
Funding filed with regulators
DIOSynVax filed 2 raises, $1.7M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jun 2025$1.7MUK share allotment
- Apr 2022Amount not statedUK share allotment
Founders and team
From DIOSynVax's own website: 6 on the team.
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about DIOSynVax
How much has DIOSynVax raised?
DIOSynVax has raised $44M across 2 rounds since 2022.
When did DIOSynVax last raise?
DIOSynVax's most recent round, $1.7M, was in Jun 2025.
What was DIOSynVax's biggest round?
DIOSynVax's largest round on record is $42M (Grant), in Mar 2022.
Who backed DIOSynVax first?
DIOSynVax's first round on record, in Mar 2022, was backed by Innovate UK and Parkwalk.
What stage is DIOSynVax at?
DIOSynVax's latest named round is a Grant, in Mar 2022.
Where is DIOSynVax based?
DIOSynVax is based in the United Kingdom.
Companies like DIOSynVax
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.